- Recommendation ID
- NG242/1
- Question
What are the clinical features or factors that suggest treatment should be switched or stopped for people with diabetic macular oedema?
- Any explanatory notes
(if applicable) For a short explanation of why the committee made this recommendation for research, see the rationale section on when to add, switch or stop treatment .
Full details of the evidence and the committee's discussion are in evidence review H: clinical features or factors that suggest treatment should be switched or stopped for people diagnosed with proliferative diabetic retinopathy or diabetic macular oedema.
Source guidance details
- Comes from guidance
- Diabetic retinopathy: management and monitoring
- Number
- NG242
- Date issued
- August 2024
Other details
| Is this a recommendation for the use of a technology only in the context of research? | No |
| Is it a recommendation that suggests collection of data or the establishment of a register? | No |
| Last Reviewed | 28/01/2025 |